InsiderTrades.com logo
Bronwen Bastone net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Bronwen Bastone Biography and Net Worth

Chief People Officer of Enfusion

Bronwen Bastone is Chief People Officer at Enfusion. She is responsible for rapidly scaling Enfusion’s approach to human resources. She has 20 years of experience in HR leadership roles across multiple industries, including institutional finance.

Previously, she led HR at Exos, a B2B institutional finance platform. She has also held senior HR roles at Knight Capital, Merrill Lynch, Cushman Wakefield, Brookfield Asset Management, and Southwest Power Pool. She holds an MBA from the University of Technology, Sydney (Australia).

What is Bronwen Bastone's net worth?

The estimated net worth of Bronwen Bastone is at least $2.47 million as of March 5th, 2025. Ms. Bastone owns 221,875 shares of Enfusion stock worth more than $2,472,797 as of March 31st. This net worth approximation does not reflect any other investments that Ms. Bastone may own. Additionally, Ms. Bastone receives an annual salary of $566,250.00 as Chief People Officer at Enfusion. Learn More about Bronwen Bastone's net worth.

How old is Bronwen Bastone?

Ms. Bastone is currently 51 years old. There are 6 older executives and no younger executives at Enfusion. The oldest executive at Enfusion is Mr. Bradley Herring, Chief Financial Officer, who is 53 years old. Learn More on Bronwen Bastone's age.

What is Bronwen Bastone's salary?

As the Chief People Officer of Enfusion, Inc., Ms. Bastone earns $566,250.00 per year. There are 2 executives that earn more than Ms. Bastone. The highest earning executive at Enfusion is Mr. Oleg Movchan, CEO & Director, who commands a salary of $834,790.00 per year. Learn More on Bronwen Bastone's salary.

How do I contact Bronwen Bastone?

The corporate mailing address for Ms. Bastone and other Enfusion executives is , , . Enfusion can also be reached via phone at 312-253-9800 and via email at brian.murphy@icrinc.com. Learn More on Bronwen Bastone's contact information.

Has Bronwen Bastone been buying or selling shares of Enfusion?

Within the last three months, Bronwen Bastone has sold $67,463.77 in shares of Enfusion stock. Most recently, Bronwen Bastone sold 3,126 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a transaction totalling $35,573.88. Following the completion of the sale, the insider now directly owns 221,875 shares of the company's stock, valued at $2,524,937.50. Learn More on Bronwen Bastone's trading history.

Who are Enfusion's active insiders?

Enfusion's insider roster includes Bronwen Bastone (Chief People Officer), Matthew Campobasso (General Counsel), Dan Groman (Chief Technology Officer), Bradley Herring (CFO), Roy Luo (Director), Oleg Movchan (CEO), Neal Pawar (Chief Operating Officer), and Deirdre Somers (Director). Learn More on Enfusion's active insiders.

Are insiders buying or selling shares of Enfusion?

During the last twelve months, insiders at the sold shares 29 times. They sold a total of 160,582 shares worth more than $1,648,833.48. The most recent insider tranaction occured on March, 6th when CEO Oleg Movchan sold 11,452 shares worth more than $130,438.28. Insiders at Enfusion own 36.4% of the company. Learn More about insider trades at Enfusion.

Information on this page was last updated on 3/6/2025.

Bronwen Bastone Insider Trading History at Enfusion

See Full Table

Bronwen Bastone Buying and Selling Activity at Enfusion

This chart shows Bronwen Bastone's buying and selling at Enfusion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$67ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

Enfusion Company Overview

Enfusion logo
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $11.15
Low: $11.03
High: $11.16

50 Day Range

MA: $11.18
Low: $11.01
High: $11.50

2 Week Range

Now: $11.15
Low: $7.83
High: $11.80

Volume

743,057 shs

Average Volume

554,032 shs

Market Capitalization

$1.44 billion

P/E Ratio

278.69

Dividend Yield

N/A

Beta

0.95